Tag: Hu Zhiqiang
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
South Korea’s maritime hub status grows with advanced ports, shipbuilding strength, trade volumes and dispute resolution.